We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$5.69B
AUM Growth
-$527M
Cap. Flow
-$681M
Cap. Flow %
-11.98%
Top 10 Hldgs %
44.35%
Holding
882
New
93
Increased
308
Reduced
393
Closed
87

Sector Composition

Rank Sector Weight
1 Financials 13.89%
2 Technology 9.88%
3 Healthcare 7.2%
4 Energy 6.87%
5 Real Estate 3.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLR
126
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$6.06M 0.11%
143,883
+73,597
+105% +$3.14M
NVTA
127
DELISTED
Invitae Corporation
NVTA
$6.04M 0.11%
257,106
+138,784
+117% +$2.95M
RTX icon
128
RTX Corp
RTX
$294B
$5.96M 0.1%
72,733
-24,819
-25% -$2.08M
XEC
129
DELISTED
CIMAREX ENERGY CO
XEC
$5.93M 0.1%
99,991
+58,424
+141% +$3.74M
CTRA
130
DELISTED
Coterra Energy
CTRA
$5.86M 0.1%
255,219
+118,004
+86% +$3M
APA icon
131
APA Corp
APA
$12.3B
$5.84M 0.1%
201,671
+128,521
+176% +$4M
ALL icon
132
Allstate
ALL
$67.3B
$5.84M 0.1%
57,439
-9,646
-14% -$942K
AVB icon
133
AvalonBay Communities
AVB
$26.8B
$5.73M 0.1%
28,198
-3,836
-12% -$777K
MCO icon
134
Moody's
MCO
$84.2B
$5.64M 0.1%
28,858
-4,849
-14% -$920K
GHDX
135
DELISTED
Genomic Health, Inc.
GHDX
$5.62M 0.1%
96,676
+40,643
+73% +$2.41M
MRO
136
DELISTED
Marathon Oil Corporation
MRO
$5.59M 0.1%
393,364
+249,536
+173% +$3.86M
EQR icon
137
Equity Residential
EQR
$25.2B
$5.59M 0.1%
73,612
-9,948
-12% -$760K
MTDR icon
138
Matador Resources
MTDR
$5.86B
$5.58M 0.1%
280,602
+130,957
+88% +$2.49M
IMMU
139
DELISTED
Immunomedics Inc
IMMU
$5.55M 0.1%
400,010
+96,683
+32% +$1.45M
LGND icon
140
Ligand Pharmaceuticals
LGND
$5.96B
$5.52M 0.1%
77,516
+2,468
+3% +$182K
RARE icon
141
Ultragenyx Pharmaceutical
RARE
$2.65B
$5.49M 0.1%
86,501
+21,478
+33% +$1.37M
KYNB
142
Kyntra Bio
KYNB
$28.5M
$5.49M 0.1%
4,861
+1,246
+34% +$1.36M
CLVS
143
DELISTED
Clovis Oncology, Inc.
CLVS
$5.46M 0.1%
367,079
+186,542
+103% +$3.37M
FOLD
144
DELISTED
Amicus Therapeutics
FOLD
$5.44M 0.1%
435,605
+79,212
+22% +$1.01M
MRTX
145
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$5.4M 0.1%
52,453
-19,043
-27% -$1.48M
ACAD icon
146
Acadia Pharmaceuticals
ACAD
$4.35B
$5.38M 0.09%
201,255
+8,735
+5% +$223K
EXEL icon
147
Exelixis
EXEL
$14B
$5.36M 0.09%
250,969
+35,719
+17% +$749K
BLUE
148
DELISTED
bluebird bio
BLUE
$5.34M 0.09%
3,244
+486
+18% +$841K
EXAS
149
DELISTED
Exact Sciences
EXAS
$5.34M 0.09%
45,260
-12,830
-22% -$1.29M
RRC icon
150
Range Resources
RRC
$8.85B
$5.33M 0.09%
764,213
+477,415
+166% +$4.15M

Similar funds

Rafferty Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Rafferty Asset Management held 882 positions worth $5.69B, down 8.5% from $6.22B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Rafferty Asset Management withdrew a net $681M in Q2 2019, closing 87 positions and reducing 393 holdings. Its most notable exit was State Street Energy Select Sector SPDR ETF, an estimated $266M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Rafferty Asset Management opened a new position in SLB Ltd worth $7.45M.

  • Rafferty Asset Management's largest Q2 2019 buy was SLB Ltd: 187,346 shares worth $7.45M.
  • Rafferty Asset Management added most to ExxonMobil in Q2 2019, an estimated $37.1M increase.
  • Rafferty Asset Management's biggest Q2 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $187M.
  • Rafferty Asset Management fully exited State Street Energy Select Sector SPDR ETF in Q2 2019, selling an estimated $266M.
  • Rafferty Asset Management's ten largest holdings make up 44% of its $5.69B portfolio in Q2 2019.
  • Rafferty Asset Management opened 93 new positions and closed 87 in Q2 2019.
  • Rafferty Asset Management's portfolio value fell 8.5% quarter-over-quarter to $5.69B.

Based on Rafferty Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.